Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Apyx Medical CorpAPYX · Entity 6609 | Director | August 10, 2023 | August 15, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Apyx Medical Corp
Report date August 10, 2023 · Filed August 15, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Option to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.25 · Expires 2033-08-10 | Direct | 17,000 |
Reported balance
After 2023-08-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-08-10 · Grant · Disposed 17,000 · Balance 17,000 F1: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2023 Filed Aug 15, 2023 16:27 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 17,000 | $0.00 Strike: $4.25 | $0.00 |
DisclosureSEC source: 0001493152-23-028919 · ownership.xml · derivative · entry 1 MAKRIDES ANDREW · CIK 0001280517 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2033-08-10 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. Read SEC document |
| August 11, 2022 Filed Aug 17, 2022 19:45 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 17,000 | $0.00 Strike: $10.28 | $0.00 |
DisclosureSEC source: 0000719135-22-000077 · wf-form4_166076550885302.xml · derivative · entry 1 MAKRIDES ANDREW · CIK 0001280517 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2032-08-11 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. Read SEC document |
| July 05, 2022 Filed Jul 11, 2022 19:54 UTC | Apyx Medical Corp APYX · Entity 6609 | Exercise / conversionStock Option (Option to Buy) · Derivative | 30,000 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0000719135-22-000052 · wf-form4_165756924065310.xml · derivative · entry 3 MAKRIDES ANDREW · CIK 0001280517 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2022-07-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Reporting Person was granted a stock option that vested and became exercisable over 5 years at a rate of 20% of the option on the anniversary date of each year. Read SEC document |
| July 05, 2022 Filed Jul 11, 2022 19:54 UTC | Apyx Medical Corp APYX · Entity 6609 | Tax withholdingCommon Stock | 13,583 | $6.14 | $83,399.62 |
DisclosureSEC source: 0000719135-22-000052 · wf-form4_165756924065310.xml · nonDerivative · entry 2 MAKRIDES ANDREW · CIK 0001280517 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 624,389 F1 · kind: Represents a "net exercise" of outstanding stock options. Read SEC document |
| July 05, 2022 Filed Jul 11, 2022 19:54 UTC | Apyx Medical Corp APYX · Entity 6609 | Exercise / conversionCommon Stock | 30,000 | $2.54 | $76,200.00 |
DisclosureSEC source: 0000719135-22-000052 · wf-form4_165756924065310.xml · nonDerivative · entry 1 MAKRIDES ANDREW · CIK 0001280517 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 637,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 06, 2021 Filed Aug 11, 2021 16:25 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 17,000 | $0.00 Strike: $9.42 | $0.00 |
DisclosureSEC source: 0000719135-21-000051 · wf-form4_162869909025342.xml · derivative · entry 1 MAKRIDES ANDREW · CIK 0001280517 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2031-08-06 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. Read SEC document |
| August 06, 2020 Filed Aug 10, 2020 21:22 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 17,000 | $4.98 Strike: $4.98 | $84,660.00 |
DisclosureSEC source: 0000719135-20-000063 · wf-form4_159709453893549.xml · derivative · entry 1 MAKRIDES ANDREW · CIK 0001280517 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2030-08-06 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. Read SEC document |
| August 01, 2019 Filed Aug 5, 2019 20:47 UTC | Apyx Medical Corp APYX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 17,000 | $0.00 Strike: $7.28 | $0.00 |
DisclosureSEC source: 0000719135-19-000037 · wf-form4_156503801000441.xml · derivative · entry 1 MAKRIDES ANDREW · CIK 0001280517 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2029-08-01 F1 · derivative.exercise_date: Reporting person was granted a stock option under the director compensation plan which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. Read SEC document |
| November 08, 2018 Filed Nov 9, 2018 20:03 UTC | Apyx Medical Corp BVX · Entity 6609 | GiftCommon Stock | 2,000 | $6.84 | $13,680.00 |
DisclosureSEC source: 0000719135-18-000078 · wf-form4_154179376796057.xml · nonDerivative · entry 3 MAKRIDES ANDREW · CIK 0001280517 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 605,972 F1 · balance_after: The reporting person owns an aggregate of 605,972 shares of the issuer's Common Stock following all of the transactions reported on this Form 4. Read SEC document |
| November 08, 2018 Filed Nov 9, 2018 20:03 UTC | Apyx Medical Corp BVX · Entity 6609 | GiftCommon Stock | 2,000 | $6.84 | $13,680.00 |
DisclosureSEC source: 0000719135-18-000078 · wf-form4_154179376796057.xml · nonDerivative · entry 2 MAKRIDES ANDREW · CIK 0001280517 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 607,972 F1 · balance_after: The reporting person owns an aggregate of 605,972 shares of the issuer's Common Stock following all of the transactions reported on this Form 4. Read SEC document |
| November 08, 2018 Filed Nov 9, 2018 20:03 UTC | Apyx Medical Corp BVX · Entity 6609 | GiftCommon Stock | 2,000 | $6.84 | $13,680.00 |
DisclosureSEC source: 0000719135-18-000078 · wf-form4_154179376796057.xml · nonDerivative · entry 1 MAKRIDES ANDREW · CIK 0001280517 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 609,972 F1 · balance_after: The reporting person owns an aggregate of 605,972 shares of the issuer's Common Stock following all of the transactions reported on this Form 4. Read SEC document |
| August 30, 2018 Filed Sep 10, 2018 15:33 UTC | Apyx Medical Corp BVX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 12,000 | $0.00 Strike: $5.30 | $0.00 |
DisclosureSEC source: 0000719135-18-000068 · wf-form4_153659360662752.xml · derivative · entry 1 MAKRIDES ANDREW · CIK 0001280517 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2028-08-29 F1 · derivative.exercise_price: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. Read SEC document |
| September 14, 2017 Filed Sep 27, 2017 13:05 UTC | Apyx Medical Corp BVX · Entity 6609 | GrantStock Option (Option to Buy) · Derivative | 12,000 | $0.00 Strike: $2.85 | $0.00 |
DisclosureSEC source: 0000719135-17-000048 · wf-form4_150651752184882.xml · derivative · entry 1 MAKRIDES ANDREW · CIK 0001280517 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-09-13 F1 · derivative.exercise_price: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.